While the correlation analysis supports the role of NFIB in HER2+ breast carcinogenesis, it does not exclude its function in other subtypes of breast cancer or other cancers considering the complex molecular signature and tumor heterogeneity in those cases. The gene discussed is ERBB2; the disease is breast cancer.